Electrophysiological studies of excitable organs usually focus on action potential (AP)-generating cells, whereas nonexcitable cells are generally considered as barriers to electrical conduction. Whether nonexcitable cells may modulate excitable cell function or even contribute to AP conduction via direct electrotonic coupling to AP-generating cells is unresolved in the heart: such coupling is present in vitro, but conclusive evidence in situ is lacking. We used genetically encoded voltage-sensitive fluorescent protein 2.3 (VSFP2.3) to monitor transmembrane potential in either myocytes or nonmyocytes of murine hearts. We confirm that VSFP2.3 allows measurement of cell type-specific electrical activity. We show that VSFP2.3, expressed solely in nonmyocytes, can report cardiomyocyte AP-like signals at the border of healed cryoinjuries. Using EM-based tomographic reconstruction, we further discovered tunneling nanotube connections between myocytes and nonmyocytes in cardiac scar border tissue. Our results provide direct electrophysiological evidence of heterocellular electrotonic coupling in native myocardium and identify tunneling nanotubes as a possible substrate for electrical cell coupling that may be in addition to previously discovered connexins at sites of myocyte-nonmyocyte contact in the heart. These findings call for reevaluation of cardiac nonmyocyte roles in electrical connectivity of the heterocellular heart. 
H eart muscle is composed of electrically excitable [i.e., action potential (AP)-generating] myocytes, which perform the mechanical core work essential for cardiac function, and nonexcitable (incapable of AP generation) nonmyocytes, which are crucial for cardiac development, structural integrity, biochemical signaling, and tissue repair (1) . Nonmyocytes, mainly interstitial and endothelial cells, represent a heterogeneous, dynamic group of nonexcitable cells that outnumber myocytes, although they occupy a smaller volume fraction (2) . Whereas paracrine and structural roles of nonmyocytes are wellestablished in the mammalian heart, awareness of their potential role in electrical signal propagation has only started to emerge (3, 4) .
According to current concepts, the cardiac interstitium (consisting of extracellular matrix and cells) forms barriers to AP conductionmost notably in fibrous layers that separate sequentially activated heart regions or in postinjury scars. The possibility that nonmyocytes may contribute to cardiac electrical connectivity is not generally considered in situ and would require direct electrotonic connections between cardiac myocytes and nonmyocytes in native heart tissue.
Such heterocellular electronic coupling could involve connexin proteins found at points of cardiomyocyte-nonmyocyte contact in the myocardium (5) . Possible functionality of connexin-based junctions was indicated in rabbit atrium, where dye diffusion between heterotypic cell types has been reported (6) , and in mouse ventricle, where fibroblast-specific conditional connexin 43 knockout reduced transmission of injected current from healthy to scarred tissue (7) . A number of clinical observations, such as transscar electrical conduction after atrial ablation (8) or surgical repair of congenital heart defects (9) and transplantation (10) , in addition to experimental findings of electrical conduction into postinfarct (11) and cryoinjury (7) scars and along implanted tissue grafts (12, 13) would be in keeping with a (passive) contribution by nonmyocytes to cardiac AP conduction. Functional heterocellular electrotonic coupling thus far has been shown conclusively in vitro only [where it is aided by phenotype conversion and connexin overexpression of cultured fibroblasts (14) (15) (16) (17) ]. Direct confirmation in situ by classic electrophysiological means is lacking, perhaps because the high membrane resistance and low capacitance of fibroblasts mean that myocytes "AP-clamp" directly coupled fibroblasts (18) . As a result, microelectrode recordings cannot reliably distinguish electrotonically coupled nonmyocytes from myocytes in native heart tissue. Surface electrical and dye-based optical mapping of multicellular activity equally cannot assess heterocellular coupling, because these signals are not population-specific and are dominated by cardiomyocyte activity.
In contrast, optogenetic techniques allow for cell type-specific recordings. To determine whether heterocellular electrotonic coupling occurs in native myocardium, we expressed an mCerulean-Citrine (CFP-YFP) FRET-based voltage reporter [voltage-sensitive fluorescent protein 2.3 (VSFP2.3) (19) ] exclusively in either cardiomyocytes Significance Heart pumping is triggered and coordinated by action potentials (APs) originating in and spreading among electrically excitable heart muscle cells (myocytes) via electrotonic coupling. Cardiac nonmyocytes are thought not to participate in AP conduction in situ, although heterocellular electrotonic coupling is common in cell culture. We used optogenetic tools involving cell-specific expression of a voltage-reporting fluorescent protein to monitor electrical activity in myocytes or nonmyocytes of mouse hearts. We confirm the suitability of this technique for measuring cell typespecific voltage signals and show that, when expressed in nonmyocytes, myocyte AP-like signals can be recorded in cryoinjured scar border tissue. This direct evidence of heterocellular electrotonic coupling in the whole heart necessitates a review of current concepts on cardiac electrical connectivity.
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Results
Myocyte-Specific VSFP2.3 Expression and Voltage Mapping. We first used double-transgenic αMHC;VSFP2.3 mice to assess the suitability of VSFP2.3 with our indicator mouse line for monitoring cardiac electrical activity and to evaluate typical myocyte-generated voltage signal dynamics in our preparation. Presence and spatial distribution of VSFP2.3 expression were established by YFP fluorescence imaging from the whole heart ( Fig. 1 A and B) and anti-YFP antibody staining in histological sections of left ventricular (LV) tissue ( Fig. 1 C and D) . In αMHC;VSFP2.3 +;+ mice, VSFP2.3 is located at the sarcolemma of cardiomyocytes (Fig. 1C) , whereas controls lacking one transgene (αMHC;VSFP2.3 −;+ or αMHC;VSFP2.3
) show no discernible VSFP2.3 expression (e.g., Fig. 1D ). Targeting efficacy of VSFP2.3 in αMHC;VSFP2.3 +;+ mice was assessed by immunohistochemical staining of VSFP2.3 (YFP antibody), cell nuclei (DAPI), and myocytes (antisarcomeric α-actinin antibody). Colabeling showed that 98.3 ± 0.5% of myocytes express VSFP2.3 ( Fig. 1E ) (3,170 myocytes, 21 tissue regions, and eight sections from three mice analyzed).
Cardiac electrical activity was studied by epicardial microscopic fluorimetry in excised, excitation-contraction uncoupled (blebbistatin; to exclude motion-related artifacts), Langendorff-perfused hearts from αMHC;VSFP +;+ mice. Collection of CFP and YFP fluorescence (300 × 600-μm area) allows measurement of myocyte AP in αMHC;VSFP2.3 +;+ hearts (n = 8). Membrane depolarization decreases CFP and increases YFP fluorescence, enabling signal enhancement by YFP/CFP ratiometry ( Fig. 2A) . To assess VSFP2.3 signal kinetics, hearts were additionally (and cell-indiscriminately) stained by coronary perfusion of a voltage-sensitive fluorescent dye (di-4-ANBDQPQ) (22) . As in a previous report (23) , VSFP2.3 reliably captures cardiac AP presence. Because of slow voltagereporting kinetics, the recorded time course of the AP shows an apparently slower AP upstroke and delayed repolarization compared with di-4-ANBDQPQ signals (Fig. 2B, Fig. S1 , and Movie S1 vs. Movie S2).
Nonetheless, these results confirm the utility of VSFP2.3 for mapping of myocyte-specific electrical activity in the murine whole heart.
Nonmyocyte-Specific VSFP2.3 Expression and Voltage Mapping. To determine whether cardiomyocytes transmit their AP waveforms into nonmyocytes, WT1;VSFP2.3 double-transgenic mice were used. It has been shown previously that scarring potentially enhances heterocellular electrotonic coupling (24, 25) and that WT1 is up-regulated by cardiac injury (26) . Therefore, WT1;VSFP2.3 +;+ and WT1;VSFP2.3 +;− mice were subjected to standardized LV epicardial cryoinjury (or sham operation) to focus enhanced expression of VSFP2.3 to nonmyocytes potentially involved in heterocellular electrotonic coupling and studied at 8 wk (±1 d) postsurgery.
Trichrome staining of whole-heart slices shows a compact, nontransmural scar in the cryoinjured LV subepicardium with nearly no surviving myocytes in the bulk scar tissue (Fig. 3H ). Presence and spatial distribution of VSFP2.3 expression were assessed by anti-YFP antibody staining in histological sections, as above. Fluorescence from interstitial nonmyocytes is increased after cryoinjury in WT1;VSFP2.3 +;+ mice (Fig. 3A) compared to sham-operated control animals ( Fig. 3 C and E To determine cell type specificity of VSFP2.3 expression, immunohistochemical analysis of slices from cryoinjured, sham-operated, and intervention-free WT1;VSFP2.3 +;+ mice was performed as above, with the addition of nonmyocyte staining (antivimentin antibody). Colabeling of YFP and sarcomeric α-actinin showed that virtually no myocytes express VSFP2.3 in cryoinjured WT1;VSFP2. Fig. 3N ) (71.1 ± 1.6%; 11,850 cells, 25 regions, 15 sections, three mice).
Epicardial fluorescence was assessed microscopically (600 × 600-μm area) by sequential measurements across the LV surface of Langendorff-perfused hearts from cryoinjured, sham-operated, and intervention-free WT1;VSFP2.3 +;+ mice. No dynamic changes in VSFP2.3 fluorescence were seen in remote tissue or the central scar of cryoinjured hearts (n = 4) (Fig. 4 ) or in sham-operated (n = 4) and intervention free (n = 4) controls, indicating either a lack of significant transmembrane potential changes in cardiac nonmyocytes or, if present, inadequate signal strength to observe them. In contrast, clear VSFP2.3 signal changes resembling myocardial AP waveforms in shape and time course were recorded at the border between cryoinjured and healthy tissue (in three of four cryoinjured hearts) (Fig. 4, Fig. S2 , and Movie S3) and, with lower amplitude, in adjacent tissue (Fig. 4) . This observation suggests that, in the border zone, nonmyocytes can be electrotonically driven by electrically coupled cardiomyocytes to passively display AP-like potential oscillations.
Overall, our results show that WT1-driven expression of VSFP2.3 occurs in a significant fraction of cardiac nonmyocytes (but not of myocytes) and that this fraction is up-regulated after cryoinjury. In scar border tissue, VSFP2.3 reports the electrical signature activity generated by excitable heart muscle cells, although the reporter protein is expressed near-exclusively in electrically nonexcitable nonmyocytes (i.e., in ∼60% of vimentin-positive nonmyocytes vs. ∼0.06% of myocytes-four orders of magnitude separation). This sham-operated animals (a rare example of a VSFP2.3-expressing myocyte is shown in Inset) but high nonmyocyte-specific expression in the remote tissue of (K) cryoinjured and (L) sham hearts, which increases (M) in the scar border and (N) into the scar. Data are presented as mean ± SEM; n ≥ 26 per group.
effect can be explained by electrotonic coupling of myocytes and nonmyocytes in the scar border zone and propagation of APshaped polarizations from the former to the latter. This finding provides direct evidence for functional electrical signal transmission from myocytes to nonmyocytes in whole heart.
Structural Connectivity of Myocytes and Nonmyocytes. Plausible structural substrates for heterocellular electrotonic coupling include previously identified connexin-based junctions between cardiac myocytes and nonmyocytes in situ (5) but potentially also tunneling nanotubes (27) . These direct membrane connections have been shown to support heterocellular communication (28) , including electrotonic coupling (29), in vitro. To investigate 3D nanoscale interrelations of myocytes and nonmyocytes at the scar border of cryoinjured hearts, tissue samples were imaged by electron tomography (ET) with an isotropic voxel size of 1.02-2.55 nm.
ET revealed a high prevalence of membrane protrusions originating predominantly from nonmyocytes and extending toward/ connecting with myocytes (Fig. 5 ). These protrusions were observed in all of the ET reconstructions of scar border myocyte-nonmyocyte contact regions analyzed (seven cell pairs, 11 samples; total number of voxels analyzed >35 × 10 9 ), with one to seven protrusions per nonmyocyte-containing tomogram (275 nm across the z axis). Nonmyocyte protrusions had a mean length of 293.5 ± 44.5 nm (ranging from 39.7 nm to 1.381 μm) and a mean diameter of 22.3 ± 3.5 nm (ranging from 3.8 to 54.8 nm; 42 protrusions analyzed). No spatial preference for the point of contact along the sarcomeric structure of myocytes (relative to Z or M lines) was identifiable. Occasionally, nonmyocyte protrusions were in contact with smaller and shorter sarcolemmal projections that originate from myocytes and extend past the basement membrane ( Fig. 5D and Movie S4).
Discussion
Using an optogenetic approach for cell type-specific targeting of a genetically encoded voltage indicator, we observed myocyte APlike changes in membrane voltage in nonexcitable cells at the border of cardiac scar tissue. This finding provides functional evidence of heterocellular electrotonic coupling in the heart and calls for a revised conceptual approach to cardiac electrophysiology that acknowledges the plausibility of nonmyocyte contributions to (passive) propagation of cardiac electrical activity.
The possibility of electrotonic coupling between myocytes and nonexcitable cells and the functional significance of resulting electrical interactions for cardiac electrophysiology were first proposed some two decades ago (18) but never functionally substantiated in native myocardium [beyond circumstantial evidence from dye transfer experiments in one rabbit atrial tissue study (6) and more recent evidence from a connexin 43 knockout mouse model (7)]. There are several important clinical implications of electrical connectivity between myocytes and nonmyocytes. Electrotonic coupling may interfere with the success of therapeutic interventions, such as atrial ablation, by causing scars to become "electrically transparent" with time (perhaps, in particular, between ablation points, where scars are most narrow). Such "disappearance" of intraprocedurally confirmed lesions seems to occur in a majority of atrial ablation patients (8) . Although atrial ablation lines, placed to electrically separate adjacent muscle regions, may perhaps be discontinuous to begin with (even if, intraprocedurally, block is achieved), de novo formation of electrical conduction across continuous and fully transmural scars after surgery has also been reported (9, 10) . The simplest explanation of these phenomena is passive AP conduction via nonmyocyte bridges electrically connecting (and activating) otherwise isolated groups of cardiac myocytes, as seen in cell culture (14, 15) . Heterocellular electrotonic coupling that links groups of surviving myocytes could also explain conduction of electrical excitation into postinfarct (11) and cryoinjury scar tissue (7). It would also appear to be a key determinant of the success of engineered heterocellular tissue grafts, implanted to patch up cardiac conduction [e.g., to fix atrioventricular block (12, 13) ]. Additionally, effects of nonmyocytes on myocyte electrophysiology and AP propagation in fibrotic tissue may be arrhythmogenic by contributing to reentrant pathways and by altering excitability, repolarization, and conduction in heart muscle (30) . It may be argued that the voltage signals measured at the scar border in WT1;VSFP2.3 +;+ mice could have originated from the minute number of individual myocytes expressing the protein rather than nonmyocytes. The spurious expression of VSFP2.3 in myocytes (∼0.06% in the border zone) may potentially be explained by WT1-expressing cell progeny among myocytes (31, 32) or VSFP2.3 trafficking via the observed tunneling nanotubes [if they form continuous plasma membrane conduits as reported in some cell culture models (27) ]. However, if VSFP2.3 signals in WT1; VSFP2.3 +;+ mice had originated from myocytes, then one would expect to also observe them in other ventricular tissue regions where the fraction of VSFP2.3 expressing myocytes, if anything, is higher. These areas include remote regions of cryoinjured hearts (∼0.33%), sham-operated hearts (∼0.18%), and intervention-free hearts (∼0.22%). However, in no single case were AP-like voltage swings observed in any of these areas (n = 0/12 hearts), whereas in scar border tissue AP waveforms were seen in n = 3/4 hearts.
Although it would have been desirable to map the entire LV surface in one view, surface mapping was prevented by spatially confined localization (border zone) and limited signal strength in WT1;VSFP2.3 +;+ hearts, necessitating sequential microscopic measurements across the LV surface. The microscopic nature (600 × 600-μm area) of measurements has the advantage of further reducing the probability of contributions from VSFP2.3-expressing myocytes to observed voltage signals in WT1;VSFP2.3 +;+ hearts. Compared to the relatively uniform excitation patterns seen in αMHC;VSFP2.3 +;+ mice ( Fig. S1A and Movie S1), in WT1;VSFP2.3 +;+ mice we observed patchy, locally heterogeneous excitation, notably with no discernible lateral translocation of sources that would have been indicative of motion artifacts ( Fig.  S2 and Movie S3). Adjacent tissue regions showed similar signals, although of lower amplitude, suggesting a reduction in passively conducted signal amplitude in the direction of the scar center and reduced heterocellular electrotonic coupling in surviving myocardium with increasing distance away from the scar (Fig. 4) .
Although the use of blebbistatin eliminated discernable contractile activity, microscopic motion may be present, including the possibility of motion in the surface-normal direction. A lack of motion artifact in the AP-like signals seen at the scar border in WT1;VSFP2.3 +;+ hearts is supported by the fact that the CFP signal recorded at the same location did not show an increase in fluorescence similar to that of YFP that would indicate a contribution of motion to the recorded signals (Fig. S3) (the fact that we found no consistent decrease in CFP fluorescence during AP activity is caused by the weakness of the signal).
Thus, it seems that nonmyocytes can indeed passively mimic the electrical activity of myocytes in the heart, at least at the border of scar tissue, where there is a large myocyte-nonmyocyte interface offering a beneficial source-sink relation for myocytes to APclamp nonmyocytes. This finding corroborates the principal possibility of heterocellular electrotonic coupling of excitable and nonexcitable cells in situ. The lack of measured AP-like activity in healthy tissue (i.e., in sham WT1;VSFP2.3 +;+ mice or remote tissue of cryoinjured animals) may indicate an absence (or smaller degree) of heterocellular electrotonic coupling in these regions; alternatively, it may be accounted for by insufficient signal strength because of the lower VSFP2.3 expression per volume of intact (myocyte-dominated) tissue. One potential explanation for a difference in heterocellular electrotonic coupling is that, at the scar border, such coupling would involve "activated" nonmyocytes [e.g., myofibroblasts (30) ]. In contrast, the lack of measured electrical activity in the central scar (where VSFP2.3 expression was high) may be explained by the distance from AP-generating cells at the scar border (10 −3 -m domain), whereas nonmyocyte-mediated AP propagation terminates in the 10
-m region in cell culture (14) . Longer-distance AP propagation may be possible if passive conduction via nonmyocytes reaches AP-generating cells (acting as "repeater stations") in tissue containing a mix of both cell types, as documented for engineered tissue strands (12, 13) . Postinfarction scars, for example, tend to contain interspersed groups of surviving myocytes; this finding is less common in postablation scars (including our cryoinjured hearts).
From our results, a range of exciting research targets emerges, including the extent, regulation, and roles of heterocellular electrical connectivity in healthy and diseased cardiac tissue and the contribution (and possible cooperativity) of underlying structural substrates, such as connexins (6, 7) and tunneling nanotubes (27) (28) (29) .
Electronic coupling between excitable and nonexcitable cells would also be important for more general physiology (for instance, related to communication between neurons and neuroglia) (33) . Heterocellular electrical coupling in the CNS may be a crucial player in the development of epilepsy (34) and ischemic brain damage (35) . Additional insight into underlying mechanisms will benefit from optogenetic targeting of reporter proteins to various cell subpopulations in excitable organs.
For the heart in particular, excitable-nonexcitable cell cross-talk has potentially far-reaching conceptual, physiological, pathological, and therapeutic implications (36) , because-in the long runit may allow one to steer atrial scars to remain electrically insulating postablation (e.g., by preventing heterocellular coupling) or in contrast, to preserve uniform ventricular conduction across small postinfarct scars (by locally increasing nonmyocyte-mediated AP conduction in the heart).
Methods
Experiments were conducted under ethical approval in accordance with the United Kingdom Animals (Scientific Procedures) Act of 1986 and the Position of the American Heart Association on Research Animal Use. Methods are summarized here, and details are in SI Methods.
Animal Model, Surgical Procedures, and Isolated Heart Preparation. Cell typespecific expression of VSFP2.3 (19) was achieved by Cre-lox recombination using FLEX, which allowed for the required levels of cell specificity by preventing offtarget expression, with αMHC for targeting expression to cardiomyocytes (20) or WT1 for targeting expression to nonmyocytes (21 (22)]. For simultaneous dual-wavelength emission imaging, fluorescence at each wavelength was collected at 511 frames per second from a 300 × 600-μm area onto one-half of a 128 × 128-pixel electron multiplying charge-coupled device camera (Cascade:128+; Photometrics). For collection of a single wavelength, fluorescence was collected from a 600 × 600-μm area onto the entire camera sensor. Signals were analyzed with custom routines in MATLAB (R2014a; MathWorks).
Histology. Cryosections were imaged with a confocal laser-scanning microscope (LSM 510 Meta; Carl Zeiss). VSFP2.3 was labeled using rabbit anti-YFP antibody (ab290; Abcam) and secondary donkey anti-rabbit Alexa488 (Life Technologies). Myocytes were labeled with a mouse antisarcomeric α-actinin antibody (ab9465; Abcam) and Alexa568 (Z-25006; Life Technologies). Nonmyocytes were labeled using a guinea pig antivimentin antibody (GP53; Progen Biotechnik) and a donkey anti-guinea pig CY3 (Jackson ImmunoResearch Laboratories). Total VSFP2.3 expression was quantified by YFP immunolabeling (reported as percentage fluorescence relative to tissue area) using ImageJ (imagej.nih.gov/ij/), whereas cell specificity and efficiency of expression were measured by counting cells costained for YFP and sarcomeric α-actinin or vimentin (reported as percentage of total α-actinin-positive myocytes or vimentin-positive nonmyocytes, respectively). (Tecnai TF30; FEI) with an isotropic voxel size of 1.02-2.55 nm. Dual-axis tilt series images were back-projected to generate two single full-thickness reconstructed volumes (tomograms) using IMOD (bio3d. colorado.edu/imod/), which were combined to generate a single high-resolution 3D reconstruction (37) .
3D EM
Statistical Analysis. Values were expressed as mean ± SEM. Analyses were performed using Graphpad Prism, with a significance of P < 0.05. Differences across groups were evaluated by ANOVA followed by posthoc Dunn's test comparisons. +;− mice of either sex were subjected to sham operation (n = 4 WT1;VSFP2.3 +;+ mice, n = 2 WT1;VSFP2.3 +;− mice) or standardized LV epicardial cryoinjury (n = 4 WT1;VSFP2.3 +;+ mice, n = 3 WT1;VSFP2.3 +;− mice) to generate a nontransmural subepicardial necrotic wound that results in a scarred region. Mice were anesthetized with 4% (vol/vol) isoflurane, intubated, and mechanically ventilated with 1-2% (vol/vol) isoflurane to maintain anesthesia. The heart was exposed by a left thoracotomy, the pericardial sac was gently opened by blunt dissection, and a 3-mmdiameter metal cryoprobe, precooled with liquid nitrogen, was applied to the dry-blotted surface of the LV free wall for 10 s [in sham animals, the probe was at room temperature (RT)]. At the end of surgery, all animals received Buprenorphine for analgesia and were recovered for 8 wk before subsequent imaging.
Supporting Information
Isolated Heart Preparation. Mice were euthanized by cervical dislocation, and the heart was rapidly excised and placed in warm (37°C) followed by cold (4°C) heparin-containing (10 units/mL) normal Tyrode solution (osmolality of 300 ± 5 mOsm/kg; containing 140 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 10 mM Glucose, 10 mM Hepes with pH titrated to 7.4 by NaOH and bubbled with 100% O 2 ). After aortic cannulation, the heart was connected bubble-free to a custom Langendorff apparatus and perfused with 37°C Tyrode solution at 2 mL/min. It was positioned into a molded cradle for mechanical support in a temperature-controlled chamber filled with 37°C Tyrode solution, with the LV/cryoinjury scar facing upward. Stability of electrical activity was monitored by two monopolar Ag/AgCl pellet electrodes (PY2 73-0200; Harvard Apparatus) positioned in the bath near either side of the heart, producing an ECG signal sampled at 2 kHz with a digital oscilloscope (PicoScope 3000 Series; Pico Technology). The heart and temperature-controlled chamber were mounted on a translating stage to allow positioning of the sample for measurement of electrical activity over the entire LV surface.
Measurement of Electrical Activity. Electrical activity from the subepicardial myocardium was collected by microscopic fluorimetry, with measurements made sequentially across the surface of the left ventricle. Hearts were excitation-contraction uncoupled with 10 μM (±)-blebbistatin (Abcam) to exclude motion-related artifacts. Eight αMHC;VSFP2.3 +;+ hearts (nonsurgery controls) were additionally stained with a voltage-sensitive fluorescent dye [di-4-ANBDQPQ; acquired from the University of Connecticut Health Center (22) ] by direct injection into the aortic cannula (15-μL bolus of 35.1 mM solution in medical-grade ethanol delivered in 0.4-μL increments over 90 s; i.e., diluted in 3 mL perfusate).
Fluorescence was excited by light from a white LED (CBT-140; Luminus Devices) with suitable filters (see below) driven by a previously described custom controller (39) passing a band-pass filter and dichroic mirror. For simultaneous dual-wavelength emission imaging, fluorescence at each wavelength was collected from a 300 × 600-μm area by a 10× water-dipping lens (UMPLFLN 10XW; Olympus Corporation) mounted on an upright fluorescence microscope (BX51 WI; Olympus Corporation) projected onto one-half of a 128 × 128-pixel, 16-bit electronmultiplying CCD camera sensor (Cascade:128+; Photometrics) using an emission image splitter (Optosplit II; Cairn Research) with a dichroic mirror, band-pass filter, and long-pass filter and recorded at 511 frames per second. For collection of a single wavelength, fluorescence was collected from a 600 × 600-μm tissue area and projected onto the entire camera sensor. The camera was controlled, and signals were acquired using MultiRecorder (shared by Stefan Luther and Johannes Schröder-Schetelig, Max Planck Institute for Dynamics and Self-Organization, Gottingen, Germany; www.bmp.ds.mpg.de/multirecorder.html).
For simultaneous collection of CFP and YFP fluorescence in αMHC;VSFP2.3 mice, CFP was excited using a 440 ± 10-nm filter (ET440/20x; Chroma Technology) and a 458-nm dichroic mirror (FF458-Di02; Semrock), with CFP emission collected through a 483 ± 16-nm filter (FF01-483/32-25; Semrock) after reflection by a 506-nm dichroic mirror (FF506-Di03; Semrock) and YFP emission collected with a ≥514-nm filter (LP02-514RU; Semrock). For simultaneous collection of YFP and di-4-ANBDQPQ fluorescence from αMHC;VSFP2.3 mice, CFP and di-4-ANBDQPQ were excited using a 457 ± 25-nm filter (FF01-457/50; Semrock) and a 495-nm dichroic mirror (FF495-DiO3; Semrock), with YFP emission collected with a 650-nm dichroic mirror (FF650-Di01; Semrock) and a 550 ± 44-nm filter (FF01-550/88; Semrock) and di-4-ANBDQPQ emission collected with a ≥700-nm filter (ET700lp; Chroma). For collection of YFP fluorescence alone in WT1;VSFP2.3 mice (CFP signal was too weak to track AP-like activity), CFP was excited using a 440 ± 10-nm filter (ET440/20x) and a 458-nm dichroic mirror (FF458-Di02; Semrock) and YFP emission was collected with a ≥514-nm filter (LP02-514RU).
Signals were processed using custom routines in MATLAB (R2014a; MathWorks). Bleaching was subtracted by fitting the signal at each pixel with a second-order polynomial followed by temporal (50-Hz low-pass Butterworth) and spatial (five-point moving average) filtering and normalization of each pixel to the baseline fluorescence: ΔF(t)/F o = 100 × [F(t) − min(F)]/min(F) (%). Average signals were generated by calculating the mean of all pixels in each frame. Ratiometric signals were calculated by taking the ratio of the two FRET signals [R(t) = YFP(t)/CFP(t)] followed by normalization to the baseline value:
Movies were generated by additionally applying a lower 15% threshold to eliminate noise and scaling signals to the global maximum/minimum.
Histology. Hearts were dissected to isolate the left and right ventricles, septum, and atria. Tissue samples were embedded flat in optimum cutting temperature compound (Tissue-Tek; Sakura Finetek) and rapidly plunge-frozen in liquid nitrogen; 16-μm-thick cryosections were cut in a plane tangential to the wall surface, collected on microscope slides (SuperFrost; Thermo Scientific), and stored at −80°C. For immunolabeling, cryosections were fixed in 2% (vol/vol) paraformaldehyde for 15 min, washed with PBS for 30 min, and blocked for 1 h at RT in 1% BSA in PBS containing 0.1% Triton X-100. VSFP2.3 was labeled using rabbit anti-YFP antibody [1:1,000; overnight (O/N) at 4°C; ab290; Abcam] followed by the secondary donkey anti-rabbit Alexa488 (1:1,000; 2 h RT; Life Technologies). Myocytes were labeled with a mouse antisarcomeric α-actinin antibody (1:50; 2 h RT; ab9465; Abcam) and preconjugated with Alexa568 using a Zenon immunolabeling kit (Z-25006; Life Technologies). Nonmyocytes were identified using a guinea pig antivimentin antibody (1:100; O/N at 4°C; GP53; Progen Biotechnik) followed by the secondary donkey antiguinea pig CY3 (1:400; 2 h RT; Jackson ImmunoResearch Laboratories). Immunolabeled cryosections were mounted in antifade mounting medium (Vectashield; Vector Laboratories) with DAPI and imaged with a confocal laser-scanning microscope (LSM 510 Meta; Carl Zeiss). To quantify VSFP2.3 expression (percentage of fluorescence relative to tissue area), single optical slice images showing YFP immunolabeling were quantitatively analyzed using ImageJ (imagej.nih.gov/ij/). To determine cell specificity and efficiency of VSFP2.3 expression, cells costained for YFP and sarcomeric α-actinin or vimentin were counted and reported as percentage of total α-actinin-positive myocytes or vimentinpositive nonmyocytes, respectively.
A subset of hearts (n = 3) was fixed by coronary perfusion with 10 mL fast-acting Karnovsky's fixative (isotonic; containing 0.75% formaldehyde, 0.75% glutaraldehyde, H 2 O) and stored O/N at 4°C. They were then rinsed in cacodylate buffer (three times), dehydrated by exposure to rising alcohol concentrations [8 h in 25% (vol/vol); 1.5 h each in 50% (vol/vol), 70% (vol/vol), 80% (vol/vol), and 90% (vol/vol); and 1.5 h (three times) in 100%], treated with xylene (3 × 1.5 h), and infiltrated with wax [24 h in 50% (vol/vol) and 48 h in 100% (40) ]. Whole hearts were serially sectioned (10-μm thickness) using a heavy-duty sledge-type microtome (SM2400; Leica Microsystems). The tissue was allowed to relax in a water bath (HI 1210; Leica Microsystems) at 39°C for ∼2 min and then, carefully (aiming for minimal distortion and avoidance of tissue folds) mounted to positively charged slides (SuperFrost). Slides were air-dried (O/N) followed by dewaxing and trichrome staining using an automated stainer (ST5010 AutoStainer XL; Leica Microsystems). The stained and mounted sections were imaged at high resolution (1.2-μm x/y resolution) with an automated slide scanner (Nanozoomer HT 2.0; Hamamatsu Photonics or Axio Scan.Z1; Carl Zeiss).
3D EM Tomography. Tissue, fixed in isotonic Karnovsky's fixative, was washed with 0.1 M sodium cacodylate, postfixed in 1% OsO 4 for 1 h, dehydrated in graded acetone, and embedded in EponAraldite Resin; 275-nm-thick sections were cut and transferred onto copper slot grids and poststained with Reynolds' lead citrate followed by 2% (vol/vol) aqueous uranyl acetate. Colloidal gold particles (15 nm) were added to both surfaces of the sections as fiducial markers for use during subsequent tilt series alignment. Preparations were imaged at the Boulder Laboratory for 3D Electron Microscopy of Cells (University of Colorado) using an intermediate voltage electron microscope (Tecnai TF30; FEI) operating at 300 kV, with images captured on a CCD camera (UltraScan; Gatan). Isotropic voxel size ranged from 1.02 to 2.55 nm. For dual-axis tilt series imaging, the specimen holder was tilted from +60°to −60°at 1°intervals before the specimen was rotated by 90°in the xy plane of the holder and reimaged in a second +60°to −60°tilt series. The images from each tilt series were aligned by fiducial marker tracking and back-projected to generate two single full-thickness reconstructed volumes (tomograms), which were then combined to generate a single high-resolution 3D reconstruction of the original partial cell volume (37) . For large-area reconstruction of myocyte-nonmyocyte connections, subsequent serial sections were imaged in "super-montage mode" [3 × (2 × 3)] and joined during postprocessing, covering a total volume of 350 μm 3 . All tomograms were processed and analyzed using the IMOD software (bio3d.colorado.edu/imod/), which was also used to generate 3D models of the relevant structures of interest. Models were smoothed and meshed to obtain the final 3D representation, in which spatial relations of nonmyocyte sarcolemma, myocyte surface sarcolemma, and myocyte basement membrane are visualized.
Statistical Analysis. All values are expressed as mean ± SEM calculated from the average of the indicated number of samples in each case. Statistical analyses were performed using Graphpad Prism software, with the threshold level for significance set at P < 0.05. Differences across groups were evaluated by ANOVA when normality and equal variance tests were passed followed by comparisons between groups by posthoc Dunn's test. 
